Universität Wien

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1 (2021S)

5.00 ECTS (2.00 SWS), SPL 32 - Pharmazie
Prüfungsimmanente Lehrveranstaltung

Beginn am


Sprache: Englisch



Zur Zeit sind keine Termine bekannt.


Ziele, Inhalte und Methode der Lehrveranstaltung

The students will be introduced to basic principles in drug discovery. The course will consist of presentations given by the faculty, as well as presentations given by students, followed by round table discussions.

Art der Leistungskontrolle und erlaubte Hilfsmittel

There will be one written evaluation at the end of the course.
The grades will be deduced from the result in the written evaluation, together with taking into account class participation as well as presentation skills.
The written evaluation is done in the open book mode, i.e. students are allowed to use all the
material collected during the class and the studies for the class.

Mindestanforderungen und Beurteilungsmaßstab

The student should possess basic knowledge in principles of drug discovery. Topics will cover target identification and validation, structural biology, hit identification and validation, lead structure identification and optimization and hereby be able to understand and comprehensively and critically present original papers / projects /ideas to these topics.


All topics covered during the course.


Some useful literature can be found in the following publications:
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)

Zuordnung im Vorlesungsverzeichnis

Letzte Änderung: Do 21.01.2021 15:29